These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7374258)

  • 1. [Dysmenorrhea].
    Bråkenhielm A; Asplund J
    Lakartidningen; 1980 Mar; 77(12):1100-1. PubMed ID: 7374258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of the etiology and management of dysmenorrhea in adolescence.
    Alvin PE; Litt IF
    Pediatrics; 1982 Oct; 70(4):516-25. PubMed ID: 6812011
    [No Abstract]   [Full Text] [Related]  

  • 3. Naproxen in the treatment of OC-resistant primary dysmenorrhea. A double-blind cross-over study.
    Jacobson J; Lundström V; Nilsson B
    Acta Obstet Gynecol Scand Suppl; 1983; 113():87-9. PubMed ID: 6407271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of dysmenorrhea].
    Zahradnik HP; Breckwoldt M
    Gynakologe; 1988 Mar; 21(1):58-62. PubMed ID: 2897319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial.
    Harada T; Momoeda M; Taketani Y; Hoshiai H; Terakawa N
    Fertil Steril; 2008 Nov; 90(5):1583-8. PubMed ID: 18164001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How I manage dysmenorrhoea.
    Elliott C
    Aust Fam Physician; 1981 Aug; 10(8):596-8. PubMed ID: 7295201
    [No Abstract]   [Full Text] [Related]  

  • 7. Dysmenorrhea in women with intrauterine contraceptive device. Treatment with a prostaglandin synthetase inhibitor, naproxen.
    Lalos O; Nilsson B
    Int J Gynaecol Obstet; 1983 Feb; 21(1):33-7. PubMed ID: 6133791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications and contraindications for oral contraceptive treatment].
    Starup J
    Nord Med; 1971 Nov; 86(47):1406-7. PubMed ID: 5138113
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of primary dysmenorrhea.
    Lundström V; af Geijerstam G
    Acta Obstet Gynecol Scand Suppl; 1983; 113():83-5. PubMed ID: 6407270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard treatment of dysmenorrhea with special reference to treatment with spasmolytics and hormones.
    Osler M
    Acta Obstet Gynecol Scand Suppl; 1979; 87():69-72. PubMed ID: 288297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of various oral contraceptive combinations on dysmenorrhea.
    Milsom I; Andersch B
    Gynecol Obstet Invest; 1984; 17(6):284-92. PubMed ID: 6745736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary dysmenorrhea: current insights in etiology and treatment].
    Hein PR; Eskes TK
    Ned Tijdschr Geneeskd; 1984 Jan; 128(2):73-8. PubMed ID: 6422313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S; Robbins J; West CR; Nemeth MA
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ketorolac vs naproxen in the treatment of primary dysmenorrhea].
    Paladini A; Panella G; Iovinelli G; Corona L; Varrassi G
    Minerva Anestesiol; 1991 Oct; 57(10):1086-7. PubMed ID: 1961487
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience of naproxen in the treatment of primary dysmenorrhea.
    Dandenell LO; Lalos O; Lisciak J; Sandström B; Barany S; Nilsson B
    Acta Obstet Gynecol Scand Suppl; 1979; 87():95-100. PubMed ID: 380256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rationale for the treatment of dysmenorrhea.
    Csapo AI
    J Reprod Med; 1980 Oct; 25(4 Suppl):213-21. PubMed ID: 7001020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antagonist of prostaglandin synthesis in the treatment of dysmenorrhea].
    Nesheim B
    Tidsskr Nor Laegeforen; 1979 Jun; 99(16):847-8. PubMed ID: 462454
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of dysmenorrhea with a new prostaglandin antagonist].
    Scarrone G; Cabiati E; Maggio G; Furbatto G
    Minerva Ginecol; 1982 Dec; 34(12):1047-50. PubMed ID: 7155437
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives.
    Chan WY; Dawood MY; Fuchs F
    Am J Med; 1981 Mar; 70(3):535-41. PubMed ID: 7011011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe, primary dysmenorrhea treated with naproxen. A prospective, double-blind, crossover investigation.
    Hamann GO
    Prostaglandins; 1980 May; 19(5):651-7. PubMed ID: 6448429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.